# Clinical Study to Investigate Safety and Efficacy of GSK933776 in Adult Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration

> **NCT01342926** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 191 (actual)

## Conditions studied

- Atrophy, Geographic

## Interventions

- **DRUG:** GSK933776
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01342926
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06-01
- **Primary completion:** 2016-04-01
- **Final completion:** 2016-04-01
- **Target enrollment:** 191 (ACTUAL)
- **Last updated:** 2017-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01342926

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01342926, "Clinical Study to Investigate Safety and Efficacy of GSK933776 in Adult Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01342926. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*